Substance use disorder: contraceptive options counseling

What’s New in Contraception?

Contraceptive Technology Conference!

Biologic sexism of STIs

Excess breast cancer deaths after COVID-19

Contraception for patients with medical conditions

Pelvic Floor Dysfunction

Treating vulvodynia

Puzzling Over the Hurt Down-Under

Serious Mental Illness and Contraception

New 13-Cycle Vaginal Contraceptive System

The Future of Family Planning in Post-COVID America

New ASCCP Guidelines: Implications for FP

On the alert: mood disorders during 2020 stressors

Sex in the Time of COVID-19

Challenges old and new during the pandemic

Reproductive health in the time of Covid-19

Talking about toys

Missed Pills: The Problem That Hasn’t Gone Away

Find the “yes! . . . and” rather than “no” or “but”

Digital Family Planning: the Future is Now

Irregular Bleeding Due to Contraceptives

When she’s low on libido…

Ouch! Best approaches to menstrual pain

Contraceptive efficacy: understanding how user and method characteristics play their part

Strategizing treatment for chronic heavy menstrual bleeding


Untangling the literature on obesity and contraception

High tech apps for no-tech FABM

Menstrual exacerbation of other medical conditions

From Princeton University: Thomas James Trussell (1949-2018)

The Short and Long of IUD Use Duration

Selecting a Method When Guidance Isn’t Clear-cut

Healthcare in the Time of Digital Expansion

The Scoop on Two New FDA-Approved Contraceptive Methods

Pregnancy of unknown location—meeting the challenge

Big “yes” (with caveats) to CHCs during perimenopause

The role of IUDs (LNG IUDs, too!) in emergency contraception

Combined pills’ effect on mood disorders

Abortion in the U.S.: safe, declining, and under threat

Hope for ovarian cancer screening test

Breast cancer still a small risk with some hormonal contraceptives

New treatment modality for BV

Record rate of HPV-related throat cancer

Viruses in semen potentially transmissible

Don’t Abstain from Your Role in Abstinence

Teens births declining but geographic ‘hotspots’ defy trend

Online Medical Abortion Service Effective and Safe

Do Women Really Need to Wait That Long?

Reassuring news on depression and OC use

PMDD: Genetic clues may lead to improved treatment

Breast cancer risk when there is a family history

Body weight link to breast and endometrial cancers (and 11 others)

Family Planning in 2017 and Beyond

Make Me Cry: Depression Link (Again)?

Managing implant users’ bleeding and spotting

Zika: Updated guidance for providers

Pharmacist-prescribed contraceptives

Hot off the press! 2016 MEC and SPR

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Opioid use epidemic among reproductive-age women

Good news on the family planning home front!

War Against Planned Parenthood Hurts Women

Win-win for both treatment and prevention

Center of the Storm


Menopause, mood, mental acuity, and hormone therapy

Emergency contraception for teens

Postpartum Contraception: Now, Not Later

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Are we practicing what we preach?

Be alert to VTE in hormonal contraceptive users

LARC among teens increased 15-fold, but not enough

Brain cancer and hormonal contraception

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Alcohol consumption when pregnancy is unwanted or unintended

Latest Data on Contraceptive Use in the United States

LateBreaker sampler from Contraceptive Technology conference

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Handout on Unintended Pregnancy and Contraceptive Choice

Ask About Withdrawal (Really!)

Rules to Practice By: Safety First and Cleanliness is Close to. . .

What’s Vanity Fair Got Against the NuvaRing?

Promising New Treatment for Hepatitis C

Numbers matter, so make them simple for patients

The Recession’s Effect on Unintended Pregnancies

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Applying the “New” Cervical Cytology Guidelines in Your Practice

Acute Excessive Uterine Bleeding: New Management Strategies

Medical indications for IUD use in teens

Whatever happened to PID?

Update on Emergency Contraception New and Improved

Opioid use epidemic among reproductive-age women
June 2016


The opioid epidemic in the United States strikes the population at large and, of specific interest to family planning providers, reproductive-age women. Overdoses have led to a death rate that has been rising faster than the death rate from other causes of death, affecting nearly every county in the nation.[1] In addition to the risk of overdose, opioids lead to an array of birth defects when taken by pregnant women.

In 2015, the Centers for Disease Control and Prevention reported that medications containing opioids are widely prescribed among reproductive-aged women. Each year between 2008–2012, more than one-fourth of women (27.7%) with private insurance and more than one-third of women (39.4%) on Medicaid filled a prescription for an opioid.[2] Among privately insured women, opioid prescription claims were highest among those residing in the South. Among Medicaid-enrolled women, opioid prescription claims were highest among non-Hispanic whites.

Just this year, the CDC published another report, this one looking more closely at the fertility status of women who filled opioid prescriptions from 2008 through 2013.[3] Among all women of reproductive age residing in New York state, one-fifth (20.0%) were prescribed an opioid-containing drug. Most likely to receive a prescription were women who were either using contraceptives or were infertile; more than one in four (27.3%) of these women had been prescribed an opioid. However, prescriptions given to just under one in four women (17.3%) who did not appear to be using a contraceptive posed an additional hazard.

As the CDC warns, “This is a significant public health concern given evidence of adverse pregnancy outcomes with opioid exposure, the likelihood of exposures occurring among unrecognized or unintended pregnancies, and health care provider concerns about using other pain medications during early pregnancy… Given the high rate (approximately 50%) of unintended pregnancies in the United States, opioid use among reproductive-aged women can result in many early pregnancy exposures.”In the New York study, about one in ten (9.5%) of women who had had a live birth had been prescribed an opioid-containing drug.

Despite the high rate of opioid prescriptions reported in the study, the rate in New York was low compared with other states.3Since 1972, New York has monitored prescriptions of Schedule II controlled substances. In 2012, the state began also to electronically monitor Schedule II, III and IV controlled substances. It is likely that these programs led to fewer prescriptions of opioid-containing drugs in New York state as compared to the rest of the United States. The most commonly reported opioid prescriptions during the study period were hydrocodone, codeine, and oxycodone.

Why would women take, or be prescribed opioid-containing drugs? Most of the time, it is for treatment to manage pain associated with surgical procedures, infections, chronic diseases, and injuries, according to the CDC.[4] Compared to men, women are more likely to be prescribed opioid-containing drugs and use them for longer lengths of time. These more quickly become dependent upon the drugs than do men. And when they are taken during pregnancy, opioid use can be associated with a number of birth defects: spina bifida, glaucoma, gastroschisis, and heart defects including septal defects in the ventricles and atria, tretralogy of Fallot, hypoplastic left heart syndrome, and pulmonary valve stenosis.


[1] Park H, Block M. How the epidemic of drug overdose deaths ripples across America. NY Times, Jan. 19, 2016.

[2] Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, Honein MA. Opioid prescription claims among women of reproductive age — United States, 2008–2012. MMWR January 23, 2015 / 64(02);37­41.

[3] Gallagher BK, Shin Y, Roohan P. Opioid prescriptions among women of reproductive age enrolled in Medicaid — New York, 2008–2013. MMWR / April 29, 2016 / Vol. 65 / No. 16, p 415-7.

[4]  Center for Disease Control and Prevention. (2013). Prescription painkiller overdoses: a growing epidemic, especially among women. Atlanta, GA: Centers for Disease Control and Prevention. Available at .